Loading company…
Surface Logix develops small molecule drugs for metabolic and cardiovascular diseases.
Founded in 1999, Surface Logix develops small molecule drugs to treat metabolic and cardiovascular diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in